AN UNBIASED VIEW OF AZELAPRAG WIKIPEDIA

The decision follows observations of liver transaminitis with no clinically sizeable signs, and devoid of apparent dose dependence, in a few clients in the azelaprag arms in the STRIDES Stage 2 clinical demo for being overweight (link).” BioAge continues to be self-confident in azelaprag and may proceed to analyze the results from STRIDES, based